US stock · Healthcare sector · Biotechnology
Company Logo

Apellis Pharmaceuticals, Inc.

APLSNASDAQ

58.32

USD
-2.77
(-4.53%)
Market Closed
-9.74P/E
-12Forward P/E
-0.49P/E to S&P500
6.407BMarket CAP
- -Div Yield
Google Trends
Recent Reddit Comments
Nothing found
Recent Tweets
$APLS 150K+ LIVE #optimized #options strategies like this Olive Score 78 Make a fixed 14.5% (78.9% annualized) APLS can fall 31% thru exp before you start to lose. Buy 1 $30 put Buy 1 $35 put Sell 3 $45 puts Exp 12/16/22 https://t.co/8HMfJB81VW
0
0
0
$APLS Don't miss the next move in a few hours. https://t.co/e50vKnd3af
0
0
0
The Altman-Z score of $APLS is much better than the industry average of 0.32. https://t.co/lepgQU9JmG https://t.co/IJK1jDfuKU
0
0
0
Q4 has some great catalysts: $RLMD -P3 Reliance data $GOSS - P2 PAH data $MIST -P3 PSVT data $RCUS - ARC-7 data (P2 Tigit) $MRTX - Adagrasib (FDA decision) $APLS - Geographic Atrophy (FDA decision)
1
1
8
$APLS Easier to win, harder to lose Olive Score 75 Make up to 30.5% (58.2% annualized) APLS can fall 21% before you start to lose. Sell 1 $65 put Exp 4/21/23 https://t.co/iUM622Bzoi
0
0
0
Nice print for $APLS Size: 118586 Price: 58.32 Amount: $6,915,935.52 Time: 1600 See more: https://t.co/v6hX0Minp1 Join https://t.co/JWvlYbdLod to get REAL TIME prints. Runners 📈: https://t.co/VC1LdPHaJR Losers 📉: https://t.co/9MWV4THfhQ Gappers 🪜: https://t.co/bHQKF1W40n
0
0
0
💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰💰Congrats to all Team members for making huge gains with Trade Ideas $APLS #APLS https://t.co/rEobNg8oG4
0
0
0
😲Child abuse being done because it's a "big money maker" for the hospitals. GA patients, hide your eyes from the moneymaking stabbers and their Private Equity ownership! $ISEE $APLS
1
0
1
Vanderbilt opened its trans clinic in 2018. During a lecture the same year, Dr. Shayne Taylor explained how she convinced Nashville to get into the gender transition game. She emphasized that it's a "big money maker," especially because the surgeries require a lot of "follow ups" https://t.co/zedM7HBCBe
1154
9983
30788
SEPT20 Potential Early Buy Entries $APLS Prospective long swing on here. Potential early entry is via 30minOR breakout (today) within this 7wk darvas box. Chart below with previous entries noted. https://t.co/ejiLwTbdCN
1
0
1
If biotwitter had a short portfolio it would look like this: $SWTX $RCUS $APLS $SAGE $IDYA $MRTX It’s literally just all the best companies
1
2
9
$APLS is gonna get bought. The companies a powerhouse between their approved PNH therapy and soon to be approved blockbuster in Geographic Atrophy
0
0
4
BofA's key takeaways from their London HC conference. $APLS remains confident that its FDA application for approval of peg' in GA will be approved on time. $BNTX reiterated its FY22 13-17bn EUR guidance /will soon begin shipping the updated Covid booster to its EU territories.
0
0
0
NRTIs will treat GA and Choroidal neovasc - preserving vision- $ISEE and $APLS cause CNV while allowing g GA to steal a person’s vision more slowly- the erosion continues in spit of the in-the-Evye injections.
0
0
0
Where does $ISEE trade if $APLS gets a CRL in November?
1
2
1
$APLS $XBI I have tweeted about Apellis in the past, about my perceptions of their C3 science -- mostly positively, though with doubts about Derby and Oaks. But this is not cool. And #biotwitter will stand up for Elmo.
4
1
23
It is not the FDA's job to create a new revenue stream for retinal specialists $APLS $ISEE
3
1
9
$XBI $IBB Have learned time & again that entering stocks when much of the upside is already priced in is a great way to get burnt $APLS (NP) a good example here at nearly $7B MC, $6.2M EV Any negative news on Nov PDUFA, share price could easily get cut in half or more https://t.co/P7obq3Ew3t
1
1
4
MASSIVE 🚩 🚩🚩 for $APLS
1
0
8
@cgfran01 $APLS Please attack my ideas and not my identity. Not cool. If you wanted to know my name/background, you could’ve asked and I would’ve just told you. I think I’ve been accurate in my concerns but happy to discuss and learn where I have it wrong whenever convenient.
2
0
38
@sentivcapital @whatprobability LOL. Now do endophthalmitis and CNV... Oh wait, $APLS won't fully disclose CNV...
0
0
5
“In GA, the late stage of the untreatable dry form of AMD, overabundance of non-coding Alu RNAs is implicated in cell death of the RPE-So, NRTIs could have dual therapeutic use in AMD in treating both geographic atrophy and neovascular AMD.” Perfect Combn given $ISEE $APLS > CNV.
1
0
0